drugset
drugset / Trial / NCT01454791

Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate

NCT01454791 ↗

Phase 4 Completed 40 enrolled Brown, Theodore R., M.D., MPH Teva Neuroscience, Inc. · collab
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to assess the effect of Diclofenac Sodium Topical Gel (DSTG) on injection site reaction following self-administer glatiramer acetate in people with Multiple Sclerosis.

Timeline

Start
2011-01
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical

Indications

multiple sclerosis